OtherCardiovascular
In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist
Julien Hanson, Stephanie Rolin, Denis Reynaud, Na Qiao, Leanne P Kelley, Helen M Reid, Francois Valentin, John Tippins, B Therese Kinsella, Bernard Masereel, Cecil Pace-Asciak, Bernard Pirotte and Jean-Michel PN Dogne
Journal of Pharmacology and Experimental Therapeutics February 2, 2005, DOI: https://doi.org/10.1124/jpet.104.079301
Julien Hanson
Stephanie Rolin
Denis Reynaud
Na Qiao
Leanne P Kelley
Helen M Reid
Francois Valentin
John Tippins
B Therese Kinsella
Bernard Masereel
Cecil Pace-Asciak
Bernard Pirotte

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue
OtherCardiovascular
In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist
Julien Hanson, Stephanie Rolin, Denis Reynaud, Na Qiao, Leanne P Kelley, Helen M Reid, Francois Valentin, John Tippins, B Therese Kinsella, Bernard Masereel, Cecil Pace-Asciak, Bernard Pirotte and Jean-Michel PN Dogne
Journal of Pharmacology and Experimental Therapeutics February 2, 2005, DOI: https://doi.org/10.1124/jpet.104.079301
OtherCardiovascular
In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist
Julien Hanson, Stephanie Rolin, Denis Reynaud, Na Qiao, Leanne P Kelley, Helen M Reid, Francois Valentin, John Tippins, B Therese Kinsella, Bernard Masereel, Cecil Pace-Asciak, Bernard Pirotte and Jean-Michel PN Dogne
Journal of Pharmacology and Experimental Therapeutics February 2, 2005, DOI: https://doi.org/10.1124/jpet.104.079301